NAV
$12.78
AUM
$2.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
-1.18
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| -32.54% | -26.37% | -27.82% | -62.86% | -30.36% | -17.01% |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Inception Date: 2010-04-06